US Broker Ratings

Anavex Life Sciences Corp. (AVXL): Investor Outlook on a Biotechnology Stock with a Potential 393% Upside

Anavex Life Sciences Corp. (NASDAQ: AVXL) stands at the forefront of innovative solutions within the biotechnology sector, drawing substantial attention from investors due to its promising drug pipeline and significant..

Savara, Inc. (SVRA) Investor Outlook: An 81% Upside Potential in Rare Respiratory Disease Treatment

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is capturing investor attention with its focus on rare respiratory diseases and a promising 81% potential upside. Operating within the biotechnology sector,..

AbCellera Biologics Inc. (ABCL) Investor Outlook: Analyzing the 155% Upside Potential

AbCellera Biologics Inc. (NASDAQ: ABCL) is currently capturing the attention of investors with its significant potential upside, as indicated by a 155.34% increase potential based on analyst target price ranges...

Fulgent Genetics, Inc. (FLGT) Investor Outlook: Exploring a 35.97% Potential Upside in the Healthcare Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a significant potential upside of 35.97%, the company presents a..

Vir Biotechnology, Inc. (VIR) Stock Analysis: An Investor’s Look at a Potential 116.98% Upside

Vir Biotechnology, Inc. (NASDAQ: VIR) is catching the eye of investors with a staggering potential upside of 116.98%, making it a compelling subject in the biotechnology sector. As a clinical-stage..

Sionna Therapeutics, Inc. (SION) Stock Analysis: A Promising 24% Upside Potential in the Biotech Arena

Sionna Therapeutics, Inc. (SION) is a clinical-stage biopharmaceutical company making waves in the healthcare sector, specifically within the biotechnology industry. With its primary focus on developing innovative treatments for cystic..

ArriVent BioPharma, Inc. (AVBP): Investor Outlook with a Promising 73% Potential Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a dynamic player in the biotechnology industry, is capturing investor attention with a compelling potential upside of 73.29%. This clinical-stage biopharmaceutical company, based in Newtown..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Unveiling an 87% Potential Upside in Gene Editing Innovation

Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of innovation in the biotechnology sector, focusing on groundbreaking genome editing treatments. As a clinical-stage company, Intellia’s ambitious pipeline aims to..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Exploring 113.62% Potential Upside with Strong Buy Ratings

For investors seeking opportunities in the biotechnology sector, Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) presents a compelling case with its significant upside potential and promising pipeline. With a current market..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Promising 87% Potential Upside Captures Investor Attention

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is drawing significant attention in the biotechnology sector, primarily due to a compelling potential upside of 87.03% based on current analyst ratings. Specializing in the..

CorMedix Inc. (CRMD): Investor Outlook with a Promising 102% Upside Potential

CorMedix Inc. (NASDAQ: CRMD) is capturing investor attention with its substantial growth trajectory and impressive potential upside. As a biopharmaceutical company operating in the biotechnology sector, CorMedix is making significant..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating the Healthcare Sector with a Promising 54.9% Revenue Growth

Avadel Pharmaceuticals plc (NASDAQ: AVDL), a prominent player in the healthcare sector, operates within the specialized niche of drug manufacturing, focusing on both specialty and generic pharmaceuticals. Headquartered in Dublin,..

SI-BONE, Inc. (SIBN) Stock Analysis: Strong Buy Ratings Signal 57.73% Potential Upside

SI-BONE, Inc. (NASDAQ: SIBN), a pioneering force in the medical devices sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry. Based in Santa Clara, California, SI-BONE..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring a 111% Potential Upside in Biotech Innovation

Gyre Therapeutics, Inc. (GYRE), a dynamic player in the biotechnology sector, is drawing attention from investors with its promising pipeline of anti-inflammatory and anti-fibrotic therapies. Headquartered in San Diego, California,..

PAR Technology Corporation (PAR): Investor Outlook Highlights a Potential 184% Upside

For investors seeking high-growth opportunities within the technology sector, PAR Technology Corporation (NYSE: PAR) presents an intriguing case. With its focus on omnichannel cloud-based hardware and software solutions, PAR is..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Exploring a 44.57% Potential Upside in the Digital Advertising Sector

DoubleVerify Holdings, Inc. (NYSE: DV), a key player in the Communication Services sector, operates within the Advertising Agencies industry with a focus on enhancing the effectiveness and quality of digital..

Paycom Software, Inc. (PAYC) Investor Outlook: Exploring the 22% Potential Upside

Investors interested in the technology sector may find Paycom Software, Inc. (NASDAQ: PAYC) an intriguing opportunity, particularly given its potential upside of 22% based on current analyst ratings. This cloud-based..

Intapp, Inc. (INTA) Stock Analysis: Exploring a 97% Upside Potential in AI-Powered Solutions

Intapp, Inc. (Nasdaq: INTA), a notable player in the software application industry, presents an intriguing investment opportunity, particularly for investors keen on the transformative potential of AI-powered solutions. With a..

RingCentral, Inc. (RNG) Investor Outlook: Analyzing Growth Potential with a Forward P/E of 6.53

RingCentral, Inc. (NYSE: RNG) is a prominent player in the Technology sector, specializing in software applications that revolutionize business communications. With a market capitalization of $2.98 billion, this U.S.-based company..

HubSpot, Inc. (HUBS) Stock Analysis: Navigating a 52.52% Potential Upside

HubSpot, Inc. (NYSE: HUBS) remains a compelling story for investors seeking exposure in the technology sector, particularly within the software application industry. The company, which boasts a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds